Carlos J. Pirola

12.7k total citations · 2 hit papers
184 papers, 9.3k citations indexed

About

Carlos J. Pirola is a scholar working on Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Carlos J. Pirola has authored 184 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Epidemiology, 63 papers in Molecular Biology and 59 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Carlos J. Pirola's work include Liver Disease Diagnosis and Treatment (82 papers), Diet, Metabolism, and Disease (40 papers) and Receptor Mechanisms and Signaling (23 papers). Carlos J. Pirola is often cited by papers focused on Liver Disease Diagnosis and Treatment (82 papers), Diet, Metabolism, and Disease (40 papers) and Receptor Mechanisms and Signaling (23 papers). Carlos J. Pirola collaborates with scholars based in Argentina, United States and Italy. Carlos J. Pirola's co-authors include Silvia Sookoian, Tomas Fernández Gianotti, Gustavo Castaño, Adriana L. Burgueño, Silvia Sookoian, Carolina Gemma, Claudio González, Julio San Martino, M Rosselli and Diego Flichman and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Carlos J. Pirola

180 papers receiving 9.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

2011 693 citations Silvia Sookoian, Carlos J. Pirola profile →
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

2022 160 citations Carlos J. Pirola, Silvia Sookoian et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlos J. Pirola Argentina	52	5.1k	3.0k	2.5k	1.5k	1.3k	184	9.3k
Silvia Sookoian Argentina	49	5.8k 1.1×	2.8k 0.9×	1.6k 0.7×	1.4k 0.9×	1.1k 0.9×	139	8.6k
Ryoichi Takayanagi Japan	57	2.1k 0.4×	2.5k 0.8×	4.7k 1.9×	1.4k 1.0×	1.1k 0.9×	312	12.4k
Alex M. DePaoli United States	58	4.7k 0.9×	1.9k 0.6×	4.1k 1.7×	4.3k 2.9×	572 0.5×	100	12.6k
Brian N. Finck United States	64	4.0k 0.8×	1.9k 0.6×	8.8k 3.6×	5.7k 3.8×	2.6k 2.1×	191	17.9k
Peter A. Crawford United States	42	1.7k 0.3×	2.3k 0.8×	4.3k 1.8×	4.0k 2.7×	1.1k 0.8×	86	9.6k
Christopher J. Sinal Canada	43	3.1k 0.6×	757 0.2×	2.6k 1.1×	1.7k 1.1×	620 0.5×	85	9.0k
Andrea L. Hevener United States	45	3.7k 0.7×	1.9k 0.6×	5.3k 2.2×	5.0k 3.3×	952 0.8×	80	12.0k
Norikazu Maeda Japan	54	8.0k 1.6×	2.2k 0.7×	3.6k 1.5×	5.4k 3.6×	3.3k 2.6×	126	13.6k
Krishna Chatterjee United Kingdom	62	2.0k 0.4×	5.8k 1.9×	6.9k 2.8×	2.9k 1.9×	551 0.4×	204	14.8k
P. Nowotny Austria	49	2.2k 0.4×	2.9k 1.0×	3.3k 1.3×	4.0k 2.7×	1.2k 1.0×	204	9.2k

Countries citing papers authored by Carlos J. Pirola

Since Specialization

Citations

This map shows the geographic impact of Carlos J. Pirola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos J. Pirola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos J. Pirola more than expected).

Fields of papers citing papers by Carlos J. Pirola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos J. Pirola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos J. Pirola. The network helps show where Carlos J. Pirola may publish in the future.

Co-authorship network of co-authors of Carlos J. Pirola

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos J. Pirola. A scholar is included among the top collaborators of Carlos J. Pirola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos J. Pirola. Carlos J. Pirola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pirola, Carlos J., Tomas Fernández Gianotti, & Silvia Sookoian. (2025). The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions. Alimentary Pharmacology & Therapeutics. 61(4). 614–627. 3 indexed citations

Pirola, Carlos J., et al.. (2024). Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments. Clinical and Molecular Hepatology. 31(1). 179–195. 5 indexed citations

Schuman, Mariano, et al.. (2024). Valproate decreases transgenerationally blood pressure by affecting thyrotropin-releasing hormone promoter DNA methylation and gene expression in spontaneously hypertensive rat. Molecular and Cellular Biochemistry. 480(2). 937–949.

Pirola, Carlos J. & Silvia Sookoian. (2023). Non‐alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension. Liver International. 43(10). 2167–2176. 3 indexed citations

Pirola, Carlos J. & Silvia Sookoian. (2022). Personalized medicine in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology. 28(4). 935–938. 12 indexed citations

Salatino, Adrián, Silvia Sookoian, & Carlos J. Pirola. (2022). Computational Pipeline for Next-Generation Sequencing (NGS) Studies in Genetics of NASH. Methods in molecular biology. 2455. 203–222. 2 indexed citations

Sookoian, Silvia, et al.. (2020). Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. Gut. 69(8). 1483–1491. 145 indexed citations

Vilar‐Gómez, Eduardo, Silvia Sookoian, Carlos J. Pirola, et al.. (2020). ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. Gastroenterology. 159(3). 929–943. 21 indexed citations

García, Silvia, et al.. (2020). Cardiovascular and body weight regulation changes in transgenic mice overexpressing thyrotropin-releasing hormone (TRH). Journal of Physiology and Biochemistry. 76(4). 599–608. 8 indexed citations

10.

Pirola, Carlos J., Martín Garaycoechea, Diego Flichman, et al.. (2018). Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease. Journal of Lipid Research. 60(1). 176–185. 104 indexed citations

11.

Burgueño, Adriana L., et al.. (2013). Effect of Neonatal Clomipramine Treatment on consummatory Successive Negative Contrast. Americanae (AECID Library). 34(1). 25–36. 3 indexed citations

12.

Pirola, Carlos J., Tomas Fernández Gianotti, Adriana L. Burgueño, et al.. (2012). Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut. 62(9). 1356–1363. 288 indexed citations

13.

Sookoian, Silvia, Tomas Fernández Gianotti, Adriana L. Burgueño, & Carlos J. Pirola. (2011). Insulin resistance and epigenetic regulation: insights from human studies and prospects for future research. BioMolecular Concepts. 2(6). 445–457. 2 indexed citations

14.

Burgueño, Adriana L., et al.. (2009). The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy. Alimentary Pharmacology & Therapeutics. 31(5). 583–592. 36 indexed citations

15.

Sookoian, Silvia, Gustavo Castaño, Adriana L. Burgueño, Tomas Fernández Gianotti, & Carlos J. Pirola. (2007). Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. Journal of Hepatology. 48(1). 125–132. 73 indexed citations

16.

García, Silvia, Mariano Schuman, Adriana L. Burgueño, et al.. (2007). Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat. American Journal of Physiology-Endocrinology and Metabolism. 292(5). E1388–E1394. 22 indexed citations

17.

Heller, Paula G., Ana C. Glembotsky, Manish J. Gandhi, et al.. (2005). Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood. 105(12). 4664–4670. 65 indexed citations

18.

García, Silvia, et al.. (2002). Thyrotropin-Releasing Hormone Decreases Leptin and Mediates the Leptin-Induced Pressor Effect. Hypertension. 39(2). 491–495. 18 indexed citations

19.

Pirola, Carlos J.. (2000). Genética molecular de la hipertensión arterial esencial: genes de susceptibilidad y resistencia. Medicina-buenos Aires. 59–66. 1 indexed citations

20.

Delorenzi, Alejandro, María E. Pedreira, Arturo Romano, et al.. (1995). Acute administration of angiotensin II improves long-term habituation in the crab Chasmagnathus. Neuroscience Letters. 196(2). 193–196. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact